A $160 billion deal announced Monday to merge Pfizer and Allergan and create the world’s biggest drug company renewed the outcry in Washington over “inversions,” in which U.S. corporations combine with companies overseas to lower their tax bill.
The combination — the second-largest merger in history — could have ramifications around the globe, pushing up drug prices and spurring more such deals in the fast-consolidating health care sector and other fields.
18:13 Warren Buffett's Shareholder Letter: 5 Lessons for All Investors27
18:07 Tiny filaments, tubes proposed as Earth’s earliest fossils5
18:07 Oldest traces of life on Earth found in Quebec, dating back roughly 3.8 billion years1
03:44 Texas trucker's $6.6M haul of meth, heroin for Washington Heights dealer gets him 13 years behind bars24